SF3B1 and myelodysplastic syndrome: Mutations in SF3B1 in MDS lead to distinct splicing changes, defining a phenotype characterized by ring sideroblasts, ineffective erythropoiesis, a lower rate of leukemic transformation, and longer OS, in the absence of other unfavorable prognostic markers [29,38,39].